Medical Outsourcing in Fortaleza BR
Medical Outsourcing in Fortaleza section, includes general infrmation about Medical Outsourcing Procedure, Medical Outsourcing Fortaleza Local News, Medical Outsourcing Fortaleza Surgeon Locator and other Medical Outsourcing related material.
Medical Outsourcing Procedure
Medical Outsourcing can be defined as a health holiday. These patients going to a different country for either urgent or elective medical procedures is becoming a worldwide, multibillion-dollar industry. Medical Outsourcing is ‘cost effective’ private medical care in collaboration with the tourism industry for patients needing surgical and/or other forms of specialized treatment.
Medical Outsourcing combines wellness and healthcare alongside leisure and relaxation. Medical Outsourcing is aimed at rejuvenating a person; mentally, physically and emotionally. It involves the idea of drawing you away from your daily routine to a relaxed surrounding in an exotic location. Many medical outsourcing tourists are seeking treatment at a quarter or sometimes even a 10th of the cost at home. These patients are often people who are frustrated by long waiting times. Becoming a medical outsourcing tourist is a chance to combine a tropical vacation with elective or plastic surgery.
Countries that actively promote Medical Outsourcing include Cuba, Costa Rica, Hungary, India, Israel, Jordan, Lithuania, Malaysia and Thailand. Belgium, Poland and Singapore are now entering the field. South Africa specializes in medical safaris-visit the country for a safari, with a stopover for plastic surgery, a nose job and a chance to see lions and elephants.
Research is the first step to successful medical outsourcing travel. Make sure that you do your research on the following:
The Procedure: Find out about the procedure and compare your expectations with what is achievable by the surgery. Also inquire about follow-up care needed, time required for recovery, physical therapy, etc.
The Hospital: When selecting the hospital that is right for your needs, you should consider the hospital's accreditation, awards and recognitions, facility and equipments, statistics like success rates, etc.
The Surgeon: Check the certifications, training and repute of the surgeon who will be treating you.
The Destination Country: You should base your selection on quality, distance and cost.
Always work with your local doctor and inform him about your decision to travel overseas for treatment. You may need his assistance prior to the surgery for furnishing the health records required by the international hospital and post surgery for any follow-up checks that may be required.
More Fortaleza info...
Fortaleza By bus
As any major Brazilian city, Fortaleza can be done almost entirely by bus. Ticket price is R$ 1,60 (rare exceptions), and if you get off at a terminal you can change lines without paying again. Most lines run 7 days a week 0500-2300, give or take. The lines listed here, deemed most useful for tourists, will run roughly every 5-10 minutes daytime weekdays, frequencies perhaps halved nightime and weekends. Only the most useful parts of the routes are described. Some lines have the number 1 or 2 after their names, only to indicate direction, others don't. I.e. the very same bus with the same number and name could be running either from A to B, or from B to A. Ask!
-
Fortaleza Schooner cruises
The two motorized schooners Philosophie and Whatsitcalledagain both do 2 hour cruises along the city beaches at R$ 25 per person, setting out daily at 10:00 and 16:00 from near the Iracema-statue, where they also have their ticket booths. The latter time is better, as you get the sunset. Bring swim-gear. Minimum of ten people required- often cancelled in the low season.
Another schooner takes you all the way to Cumbuco at 09:00, lands you for lunch and has land transport back to Fortaleza. R$ 130.
-
Plastic Surgery News...
- In 1991 the alcohol-related death rate in the United Kingdom stood at 6.9 per 100,000, it rose to 12.9 per 100,000 in 2005, and then to 13.4 per 100,000 deaths in 2006, according to the Office for National Statistics. In other words, rates almost doubled from 1991 to 2006.
Context Individuals with diabetes are at increased risk for cardiovascular disease (CVD), but more aggressive targets for risk factor control have not been tested.
Objective To compare progression of subclinical atherosclerosis in adults with type 2 diabetes treated to reach aggressive targets of low-density lipoprotein cholesterol (LDL-C) of 70 mg/dL or lower and systolic blood pressure (SBP) of 115 mm Hg or lower vs standard targets of LDL-C of 100 mg/dL or lower and SBP of 130 mm Hg or lower.
Design, Setting, and Participants A randomized, open-label, blinded-to-end point, 3-year trial from April 2003-July 2007 at 4 clinical centers in Oklahoma, Arizona, and South Dakota. Participants were 499 American Indian men and women aged 40 years or older with type 2 diabetes and no prior CVD events.
Interventions Participants were randomized to aggressive (n=252) vs standard (n=247) treatment groups with stepped treatment algorithms defined for both.
Main Outcome Measures Primary end point was progression of atherosclerosis measured by common carotid artery intimal medial thickness (IMT). Secondary end points were other carotid and cardiac ultrasonographic measures and clinical events.
Results Mean target LDL-C and SBP levels for both groups were reached and maintained. Mean (95% confidence interval) levels for LDL-C in the last 12 months were 72 (69-75) and 104 (101-106) mg/dL and SBP levels were 117 (115-118) and 129 (128-130) mm Hg in the aggressive vs standard groups, respectively. Compared with baseline, IMT regressed in the aggressive group and progressed in the standard group (–0.012 mm vs 0.038 mm; P < .001); carotid arterial cross-sectional area also regressed (–0.02 mm2 vs 1.05 mm2; P < .001); and there was greater decrease in left ventricular mass index (–2.4 g/m2.7 vs –1.2 g/m2.7; P = .03) in the aggressive group. Rates of adverse events (38.5% and 26.7%; P = .005) and serious adverse events (n = 4 vs 1; P = .18) related to blood pressure medications were higher in the aggressive group. Clinical CVD events (1.6/100 and 1.5/100 person-years; P = .87) did not differ significantly between groups.
Conclusions Reducing LDL-C and SBP to lower targets resulted in regression of carotid IMT and greater decrease in left ventricular mass in individuals with type 2 diabetes. Clinical events were lower than expected and did not differ significantly between groups. Further follow-up is needed to determine whether these improvements will result in lower long-term CVD event rates and costs and favorable risk-benefit outcomes.
Trial Registration clinicaltrials.gov Identifier: NCT00047424